The Benefits of Human Papillomavirus Vaccination on Men's Health: A Literature Review
Main Article Content
Abstract
Human papillomavirus (HPV) is recognized globally as a major sexually transmitted infection that not only poses a significant health risk to women, but also causes diseases in men, such as genital warts, infertility, and oropharyngeal cancer. These conditions can reduce a man's quality of life and overall happiness. Although HPV vaccination has been a notable success in women's health, it also needs to be implemented in men. In recent years, experts have advocated the HPV vaccine for men because of its broad effectiveness and safety in preventing HPV infection and related diseases. Therefore, the purpose of this review is to comprehensively explore the diseases caused by HPV in men and the significance of HPV vaccination, in order to improve the awareness and absorption of HPV vaccination in men. The review highlights the critical importance of increasing HPV vaccine coverage in men to reduce the incidence of HPV-related diseases and improve public health outcomes.
Downloads
Article Details
References
Soheili M, Keyvani H, Soheili M, Nasseri S. Human papilloma virus: A review study of epidemiology, carcinogenesis, diagnostic methods, and treatment of all HPV-related cancers. Med J Islam Repub Iran. 2021;35:65. doi: https://doi.org/10.47176/mjiri.35.65
McBride AA. Human papillomaviruses: diversity, infection and host interactions. Nat Rev Microbiol. 2022;20(2):95-108. doi: https://doi.org/10.1038/s41579-021-00617-5
Pennycook KB, McCready TA. Condyloma Acuminata. StatPearls. Treasure Island (FL): StatPearls Publishing Copyright © 2024, StatPearls Publishing LLC.; 2024.
de Martel C, Plummer M, Vignat J, Franceschi S. Worldwide burden of cancer attributable to HPV by site, country and HPV type. Int J Cancer. 2017;141(4):664-70. doi: https://doi.org/10.1002/ijc.30716
Näsman A, Du J, Dalianis T. A global epidemic increase of an HPV-induced tonsil and tongue base cancer - potential benefit from a pan-gender use of HPV vaccine. J Intern Med. 2020;287(2):134-52. doi: https://doi.org/10.1111/joim.13010
de Martel C, Georges D, Bray F, Ferlay J, Clifford GM. Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis. Lancet Glob Health. 2020;8(2):e180-e90. doi: https://doi.org/10.1016/S2214-109X(19)30488-7
de Sanjosé S, Serrano B, Tous S, Alejo M, Lloveras B, Quirós B, et al. Burden of Human Papillomavirus (HPV)-Related Cancers Attributable to HPVs 6/11/16/18/31/33/45/52 and 58. JNCI Cancer Spectr. 2018;2(4):pky045. doi: https://doi.org/10.1093/jncics/pky045
Du EY, Adjei Boakye E, Taylor DB, Kuziez D, Rohde RL, Pannu JS, et al. Medical students’ knowledge of HPV, HPV vaccine, and HPV-associated head and neck cancer. Human Vaccines & Immunotherapeutics. 2022;18(6):2109892. doi: https://doi.org/10.1080/21645515.2022.2109892
Lockwood L, Ju X, Sethi S, Hedges J, Jamieson L. Knowledge and Awareness of HPV, the HPV Vaccine and Cancer-Related HPV Types among Indigenous Australians. International Journal of Environmental Research and Public Health. 2024;21(3):307. doi: https://doi.org/10.3390/ijerph21030307
Steben M, Durand N, Guichon JR, Greenwald ZR, McFaul S, Blake J. A National Survey of Canadian Adults on HPV: Knowledge, Attitudes, and Barriers to the HPV Vaccine. J Obstet Gynaecol Can. 2019;41(8):1125-33.e6. doi: https://doi.org/10.1016/j.jogc.2019.05.005
Suzuki Y, Sukegawa A, Nishikawa A, Kubota K, Motoki Y, Asai-Sato M, et al. Current knowledge of and attitudes toward human papillomavirus-related disease prevention among Japanese: A large-scale questionnaire study. J Obstet Gynaecol Res. 2019;45(5):994-1005. doi: https://doi.org/10.1111/jog.13929
Tusimin M, Yee CL, Razak N, Zainol MI, Minhat HS, Rejali Z. Sociodemographic determinants of knowledge and attitude in the primary prevention of cervical cancer among University Tunku Abdul Rahman (UTAR) students in Malaysia: preliminary study of HPV vaccination. BMC Public Health. 2019;19(1):1454. doi: https://doi.org/10.1186/s12889-019-7764-3
Liu Y, Di N, Tao X. Knowledge, practice and attitude towards HPV vaccination among college students in Beijing, China. Hum Vaccin Immunother. 2020;16(1):116-23. doi: https://doi.org/10.1080/21645515.2019.1638727
Galvão M, Araújo TME, Rocha SSD. Knowledge, attitudes, and practices of adolescents regarding human papillomavirus. Rev Saude Publica. 2022;56:12. doi: https://doi.org/10.11606/s1518-8787.2022056003639
Dai Z, Si M, Su X, Wang W, Zhang X, Gu X, et al. Willingness to human papillomavirus (HPV) vaccination and influencing factors among male and female university students in China. J Med Virol. 2022;94(6):2776-86. doi: https://doi.org/10.1002/jmv.27478
Winarto H, Habiburrahman M, Dorothea M, Wijaya A, Nuryanto KH, Kusuma F, et al. Knowledge, attitudes, and practices among Indonesian urban communities regarding HPV infection, cervical cancer, and HPV vaccination. PLoS One. 2022;17(5):e0266139. doi: https://doi.org/10.1371/journal.pone.0266139
Ran H, Chen Y, Gao J, Guo H, Peng S. Low awareness of HPV infection and willingness of HPV vaccination among Chinese male college students in the east of China. Front Public Health. 2022;10:971707. doi: https://doi.org/10.3389/fpubh.2022.971707
Gezimu W, Bekele F, Bekana T, Demeke A. Males' Access to Human Papillomavirus Vaccination in Resource-Limited Settings. Immunotargets Ther. 2024;13:95-8. doi: https://doi.org/10.2147/ITT.S451659
Kiener LM, Schwendener CL, Jafflin K, Meier A, Reber N, Schärli Maurer S, et al. Vaccine hesitancy and HPV vaccine uptake among male and female youth in Switzerland: a cross-sectional study. BMJ Open. 2022;12(4):e053754. doi: https://doi.org/10.1136/bmjopen-2021-053754
López N, Garcés-Sánchez M, Panizo MB, de la Cueva IS, Artés MT, Ramos B, et al. HPV knowledge and vaccine acceptance among European adolescents and their parents: a systematic literature review. Public Health Reviews. 2020;41(1):10. doi: https://doi.org/10.1186/s40985-020-00126-5
Kombe Kombe AJ, Li B, Zahid A, Mengist HM, Bounda GA, Zhou Y, et al. Epidemiology and Burden of Human Papillomavirus and Related Diseases, Molecular Pathogenesis, and Vaccine Evaluation. Front Public Health. 2020;8:552028. doi: https://doi.org/10.3389/fpubh.2020.552028
Olczak P, Roden RBS. Progress in L2-Based Prophylactic Vaccine Development for Protection against Diverse Human Papillomavirus Genotypes and Associated Diseases. Vaccines (Basel). 2020;8(4). doi: https://doi.org/10.3390/vaccines8040568
Okunade KS. Human papillomavirus and cervical cancer. Journal of Obstetrics and Gynaecology. 2020;40(5):602-8. doi: https://doi.org/10.1080/01443615.2019.1634030
Christensen ND. HPV disease transmission protection and control. Microbial Cell. 2016;3(9):476. doi: https://doi.org/10.15698/mic2016.09.530
Tripathi A, Sahu U. An overview of HPV: Causes, symptoms, and clinical manifestations. Immunopathology, Diagnosis and Treatment of HPV Induced Malignancies. 2022:1-19.
Chilaka VN, Navti OB, Al Beloushi M, Ahmed B, Konje JC. Human papillomavirus (HPV) in pregnancy–An update. European Journal of Obstetrics & Gynecology and Reproductive Biology. 2021;264:340-8. doi: https://doi.org/10.1016/j.ejogrb.2021.07.053
Taqaddas A. Effective and simple methods of preventing the transmission of viral diseases. Journal of Advancement in Medical and Life Sciences. 2020;7(4):1-9.
Suneja G, Viswanathan A. Gynecologic malignancies. Hematology/Oncology Clinics. 2020;34(1):71-89. doi: https://doi.org/10.1016/j.hoc.2019.08.018
Crocetto F, Arcaniolo D, Napolitano L, Barone B, La Rocca R, Capece M, et al. Impact of sexual activity on the risk of male genital tumors: a systematic review of the literature. International journal of environmental research and public health. 2021;18(16):8500. doi: https://doi.org/10.3390/ijerph18168500
de Sanjose S, Brotons M, Pavon MA. The natural history of human papillomavirus infection. Best practice & research Clinical obstetrics & gynaecology. 2018;47:2-13. doi: https://doi.org/10.1016/j.bpobgyn.2017.08.015
Sendagorta-Cudós E, Burgos-Cibrián J, Rodríguez-Iglesias M. Genital infections due to the human papillomavirus. Enfermedades infecciosas y microbiologia clinica (English ed). 2019;37(5):324-34. doi: https://doi.org/10.1016/j.eimc.2019.01.010
Wilson M, Wilson PJ, Wilson M, Wilson PJ. Genital warts: Springer; 2021.
Cocchio S, Bertoncello C, Baldovin T, Buja A, Majori S, Baldo V. Self-reported genital warts among sexually-active university students: a cross-sectional study. BMC infectious diseases. 2018;18:1-8. doi: https://doi.org/10.1186/s12879-018-2954-7
Richards S. An overview of genital warts. Nurs Stand. 2014;28(24):46-50. doi: https://doi.org/10.7748/ns2014.02.28.24.46.e8344
Zhu C, Wang Y, Mao W, Zhang H, Ma J. Prevalence and distribution of HPV types in genital warts in Xi’an, China: a prospective study. BMJ open. 2019;9(5):e023897. doi: https://doi.org/10.1136/bmjopen-2018-023897
Isaguliants M, Krasnyak S, Smirnova O, Colonna V, Apolikhin O, Buonaguro FM. Genetic instability and anti-HPV immune response as drivers of infertility associated with HPV infection. Infect Agent Cancer. 2021;16(1):29. doi: https://doi.org/10.1186/s13027-021-00368-1
Foresta C, Noventa M, De Toni L, Gizzo S, Garolla A. HPV-DNA sperm infection and infertility: from a systematic literature review to a possible clinical management proposal. Andrology. 2015;3(2):163-73. doi: https://doi.org/10.1111/andr.284
Wang S, Liu L, Zhang A, Song Y, Kang J, Liu X. Association between human papillomavirus infection and sperm quality: A systematic review and a meta-analysis. Andrologia. 2021;53(5):e14034. doi: https://doi.org/10.1111/and.14034
Yang Y, Jia CW, Ma YM, Zhou LY, Wang SY. Correlation between HPV sperm infection and male infertility. Asian J Androl. 2013;15(4):529-32. doi: https://doi.org/10.1038/aja.2013.36
Pereira N, Kucharczyk KM, Estes JL, Gerber RS, Lekovich JP, Elias RT, et al. Human Papillomavirus Infection, Infertility, and Assisted Reproductive Outcomes. J Pathog. 2015;2015:578423. doi: https://doi.org/10.1155/2015/578423
Barsouk A, Aluru JS, Rawla P, Saginala K, Barsouk A. Epidemiology, Risk Factors, and Prevention of Head and Neck Squamous Cell Carcinoma. Med Sci (Basel). 2023;11(2). doi: https://doi.org/10.3390/medsci11020042
Giraldi L, Collatuzzo G, Hashim D, Franceschi S, Herrero R, Chen C, et al. Infection with Human Papilloma Virus (HPV) and risk of subsites within the oral cancer. Cancer Epidemiology. 2021;75:102020. doi: https://doi.org/10.1016/j.canep.2021.102020
Lechner M, Liu J, Masterson L, Fenton TR. HPV-associated oropharyngeal cancer: epidemiology, molecular biology and clinical management. Nat Rev Clin Oncol. 2022;19(5):306-27. doi: https://doi.org/10.1038/s41571-022-00603-7
Lim YX, D’Silva NJ. HPV-associated oropharyngeal cancer: In search of surrogate biomarkers for early lesions. Oncogene. 2024;43(8):543-54. doi: https://doi.org/10.1038/s41388-023-02927-9
Li K, Wu G, Fan C, Yuan H. The prognostic significance of primary tumor size in squamous cell carcinoma of the penis. Discov Oncol. 2021;12(1):22. doi: https://doi.org/10.1007/s12672-021-00416-7
Alemany L, Cubilla A, Halec G, Kasamatsu E, Quirós B, Masferrer E, et al. Role of Human Papillomavirus in Penile Carcinomas Worldwide. Eur Urol. 2016;69(5):953-61. doi: https://doi.org/10.1016/j.eururo.2015.12.007
Kidd LC, Chaing S, Chipollini J, Giuliano AR, Spiess PE, Sharma P. Relationship between human papillomavirus and penile cancer-implications for prevention and treatment. Transl Androl Urol. 2017;6(5):791-802. doi: https://doi.org/10.21037/tau.2017.06.27
Olesen TB, Sand FL, Rasmussen CL, Albieri V, Toft BG, Norrild B, et al. Prevalence of human papillomavirus DNA and p16(INK4a) in penile cancer and penile intraepithelial neoplasia: a systematic review and meta-analysis. Lancet Oncol. 2019;20(1):145-58. doi: https://doi.org/10.1016/S1470-2045(18)30682-X
Krzowska-Firych J, Lucas G, Lucas C, Lucas N, Pietrzyk Ł. An overview of Human Papillomavirus (HPV) as an etiological factor of the anal cancer. J Infect Public Health. 2019;12(1):1-6. doi: https://doi.org/10.1016/j.jiph.2018.06.005
Alemany L, Saunier M, Alvarado-Cabrero I, Quirós B, Salmeron J, Shin HR, et al. Human papillomavirus DNA prevalence and type distribution in anal carcinomas worldwide. Int J Cancer. 2015;136(1):98-107. doi: https://doi.org/10.1002/ijc.28963
Liu X, Lin H, Chen X, Shen W, Ye X, Lin Y, et al. Prevalence and genotypes of anal human papillomavirus infection among HIV-positive vs. HIV-negative men in Taizhou, China. Epidemiol Infect. 2019;147:e117. doi: https://doi.org/10.1017/S0950268818003205
Colón-López V, Shiels MS, Machin M, Ortiz AP, Strickler H, Castle PE, et al. Anal Cancer Risk Among People With HIV Infection in the United States. J Clin Oncol. 2018;36(1):68-75. doi: https://doi.org/10.1200/JCO.2017.74.9291
Human papillomavirus vaccines: WHO position paper, May 2017. Wkly Epidemiol Rec. 2017;92(19):241-68.
Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions. N Engl J Med. 2007;356(19):1915-27. doi: https://doi.org/10.1056/NEJMoa061741
Hildesheim A, Wacholder S, Catteau G, Struyf F, Dubin G, Herrero R. Efficacy of the HPV-16/18 vaccine: final according to protocol results from the blinded phase of the randomized Costa Rica HPV-16/18 vaccine trial. Vaccine. 2014;32(39):5087-97. doi: https://doi.org/10.1016/j.vaccine.2014.06.038
Paavonen J, Jenkins D, Bosch FX, Naud P, Salmerón J, Wheeler CM, et al. Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial. Lancet. 2007;369(9580):2161-70. doi: https://doi.org/10.1016/S0140-6736(07)60946-5
Joura EA, Giuliano AR, Iversen OE, Bouchard C, Mao C, Mehlsen J, et al. A 9-valent HPV vaccine against infection and intraepithelial neoplasia in women. N Engl J Med. 2015;372(8):711-23. doi: https://doi.org/10.1056/NEJMoa1405044
Naud PS, Roteli-Martins CM, De Carvalho NS, Teixeira JC, de Borba PC, Sanchez N, et al. Sustained efficacy, immunogenicity, and safety of the HPV-16/18 AS04-adjuvanted vaccine: final analysis of a long-term follow-up study up to 9.4 years post-vaccination. Hum Vaccin Immunother. 2014;10(8):2147-62. doi: https://doi.org/10.4161/hv.29532
Ferris DG, Samakoses R, Block SL, Lazcano-Ponce E, Restrepo JA, Mehlsen J, et al. 4-Valent Human Papillomavirus (4vHPV) Vaccine in Preadolescents and Adolescents After 10 Years. Pediatrics. 2017;140(6). doi: https://doi.org/10.1542/peds.2016-3947
Olsson S-E, Restrepo JA, Reina JC, Pitisuttithum P, Ulied A, Varman M, et al. Long-term immunogenicity, effectiveness, and safety of nine-valent human papillomavirus vaccine in girls and boys 9 to 15 years of age: Interim analysis after 8 years of follow-up. Papillomavirus Research. 2020;10:100203. doi: https://doi.org/10.1016/j.pvr.2020.100203
Laserson AK, Oliffe JL, Krist J, Kelly MT. HPV Vaccine and College-Age Men: A Scoping Review. Am J Mens Health. 2020;14(6):1557988320973826. doi: https://doi.org/10.1177/1557988320973826
Castellsagué X, Giuliano AR, Goldstone S, Guevara A, Mogensen O, Palefsky JM, et al. Immunogenicity and safety of the 9-valent HPV vaccine in men. Vaccine. 2015;33(48):6892-901. doi: https://doi.org/10.1016/j.vaccine.2015.06.088
Williamson AL. Recent Developments in Human Papillomavirus (HPV) Vaccinology. Viruses. 2023;15(7). doi: https://doi.org/10.3390/v15071440
Patel C, Brotherton JM, Pillsbury A, Jayasinghe S, Donovan B, Macartney K, et al. The impact of 10 years of human papillomavirus (HPV) vaccination in Australia: what additional disease burden will a nonavalent vaccine prevent? Euro Surveill. 2018;23(41). doi: https://doi.org/10.2807/1560-7917.ES.2018.23.41.1700737
Sadlier C, Lynam A, O'Dea S, Delamere S, Quinlan M, Clarke S, et al. HPV vaccine acceptability in HIV-infected and HIV negative men who have sex with men (MSM) in Ireland. Hum Vaccin Immunother. 2016;12(6):1536-41. doi: https://doi.org/10.1080/21645515.2016.1151588
Zhou Y, Lin Y-F, Gao L, Dai J, Luo G, Li L, et al. Human papillomavirus prevalence among men who have sex with men in China: a systematic review and meta-analysis. European Journal of Clinical Microbiology & Infectious Diseases. 2021;40:1357-67. doi: https://doi.org/10.1007/s10096-021-04229-y
Persson KI. Relating to Risk: Sexual Behaviour and HIV Risk Perception Among Men Who Have Sex with Men: Karolinska Institutet (Sweden); 2018.
Rossi C, Vanhomwegen C, Laurent F. [HPV vaccination in boys and men : update and recommendations]. Rev Med Brux. 2018;39(4):352-8.
Poljak M, Šterbenc A, Lunar MM. Prevention of human papillomavirus (HPV)-related tumors in people living with human immunodeficiency virus (HIV). Expert Rev Anti Infect Ther. 2017;15(11):987-99. doi: https://doi.org/10.1080/14787210.2017.1392854
Staadegaard L, Rönn MM, Soni N, Bellerose ME, Bloem P, Brisson M, et al. Immunogenicity, safety, and efficacy of the HPV vaccines among people living with HIV: A systematic review and meta-analysis. EClinicalMedicine. 2022;52. doi: https://doi.org/10.1016/j.eclinm.2022.101585
Lacey CJ. HPV vaccination in HIV infection. Papillomavirus research. 2019;8:100174. doi: https://doi.org/10.1016/j.pvr.2019.100174
Okunade KS. Human papillomavirus and cervical cancer. J Obstet Gynaecol. 2020;40(5):602-8. doi: https://doi.org/10.1080/01443615.2019.1634030
Teng Qiuli, Niu Maoyuan, Liu Yuying. The harm of HPV infection to men and the protection of men by HPV vaccination. Chinese Journal of Immunology. 2022;38(4):507-12.